Answers are grounded in this paper and cite their sources.
N-lactoyl phenylalanine (Lac-Phe) is a circulating metabolite linked to exercise, energy metabolism, and metabolic disease. However, the metabolic determinants of circulating Lac-Phe and the influence of type 2 diabetes (T2D) on these pathways remain incompletely understood. We investigated whether the functional GCKR variant rs1260326, a strong genetic determinant of circulating lactate, is associated with Lac-Phe and whether lactate mediates this association. Genomic and clinical data were analyzed in 11,118 Qatar Biobank participants, including 2810 with untargeted metabolomic profiles. Associations of rs1260326 T-allele dosage with Lac-Phe, lactate, phenylalanine, and clinical traits were evaluated using additive linear regression adjusted for confounders. Lactate mediation of the rs1260326–Lac-Phe association was assessed using nonparametric bootstrapping and repeated after stratification by T2D status. Each copy of the rs1260326 T allele was associated with higher circulating Lac-Phe (β = 0.103, FDR = 1.7 × 10−4) and lactate (β = 0.109, FDR = 1.7 × 10−4), but not with phenylalanine (FDR = 0.95). The variant was also associated with higher triglycerides and uric acid and lower glucose. Lac-Phe and lactate associations were present in both non-T2D and T2D participants, with larger effect estimates in T2D. Lactate mediated the rs1260326–Lac-Phe association more strongly in the T2D group (43.5%) compared to the control group (13.2%). Metformin adjustment produced minimal changes in these estimates. These findings support Lac-Phe as a context-dependent metabolic signature of altered lactate-associated metabolism and highlight the influence of the diabetic metabolic environment on its genetic regulation.
No takes yet. Share an insight, caveat, or question.
Razzaq et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: